Agoracom Blog

Lexaria Closes 51% Acquisition of PoViva Tea, LLC

Posted by AGORACOM-JC at 4:39 PM on Friday, December 12th, 2014

Kelowna, British Columbia–(December 12, 2014) – Lexaria, Corp. (OTCQB: LXRP) (CSE: LXX) (the “Company”) is pleased to announce it has closed the 51% acquisition of Poviva Tea, LLC.

As the final part of the closing, Lexaria has issued 119,047 restricted common shares of the Company to each of the two founders of PoViva Tea, LLC.

All issued shares will be subject to a hold period, for any resale into the USA under Rule 144, of six months and one day. The share issuance is subject to normal regulatory approvals. The securities referred to herein will not be or have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

About Lexaria

Lexaria’s shares are quoted in the USA with symbol LXRP and in Canada with symbol LXX. The company searches for projects that could provide potential above-market returns.

To learn more about Lexaria Corp. visit www.lexariaenergy.com.

FOR FURTHER INFORMATION PLEASE CONTACT:

Lexaria Corp.
Chris Bunka
Chairman & CEO
(250) 765-6424

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. Access to capital, or lack thereof, is a major risk and there is no assurance that the Company will be able to raise required working capital. Current oil and gas production rates may not be sustainable and targeted production rates may not occur. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that the medical marijuana, CBD sector, or alternative health businesses will provide any benefit to Lexaria, or that the Company will experience any growth through participation in these sectors. There is no assurance that existing capital is sufficient for the Company’s needs or that it will need to attempt to raise additional capital. There is no assurance that and cannabidiol-based product will promote, assist, or maintain any beneficial human health conditions whatsoever. No statement herein has been evaluated by the Food and Drug Administration (FDA). PoViva products are not intended to diagnose, treat, cure or prevent any disease.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Supreme Completes Pre-License Upgrades at Kincardine Greenhouse

Posted by AGORACOM-JC at 9:22 AM on Friday, December 12th, 2014

VANCOUVER, BRITISH COLUMBIA–(Dec. 12, 2014) - Supreme Pharmaceuticals Inc. (the “Company”) (OTCBB:SPRWF) (CSE:SL) is pleased to report that the Company has completed the security and infrastructure upgrades at the hybrid industrial greenhouse facility in Kincardine, Ontario (the “Facility“) and is ready for the Health Canada pre-license inspection of the Facility.

Since the acquisition of the 342,000 sq. ft. facility in May 2014, the Company has spent approximately $4M in upgrades to transform the Facility from an out-of use tomato greenhouse to a highly secured, state-of-the-art, automated medical marijuana facility. These upgrades include a level 9 security vault capable of storing up to $150 million of dried marijuana, a sophisticated digital security system including intrusion detection and visual surveillance, as well as sanitation and automation, all which meets or exceeds the regulatory requirements set by Health Canada.

The Company and its management team have carefully planned the upgrades of the Facility to provide an optimal environment to manufacture high quality, low-cost medical marijuana. If successful in obtaining the license to produce medical marijuana subsequent to the pre-license inspection, the Company expects to immediately commence growing in its first completed phase of the Facility. Subsequent phases of the Facility are expected to be built out later in 2015 which will increase the productive capacity of the Facility. No date has been set yet for the Health Canada inspection.

John Fowler, the Company’s Director of Operations, stated: “The construction thus far has been a massive undertaking for us. We are excited to move forward in the licensing process and stay on track with our goal of providing high-quality, low-cost medical marijuana in the coming months.”

FORWARD-LOOKING INFORMATION

This news release contains forwardlooking statements and forwardlooking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forwardlooking statements or information. More particularly and without limitation, this news release contains forwardlooking statements and information relating to the obtaining of a grow license, as well as the Company’s corporate strategy. The forwardlooking statements and information are based on certain key expectations and assumptions made by management of the Company, including, without limitation, the Company’s ability to carry out its business plan following the issuance of the required licenses by Health Canada. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forwardlooking statements and information since no assurance can be given that they will prove to be correct.

Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forwardlooking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the Company’s ability to identify and complete additional suitable acquisitions to further the Company’s growth as well as risks associated with the medical marijuana industry in general such as operational risks in development and production delays or changes in plans with respect to development projects or capital expenditures; the uncertainty of the capital markets; the uncertainty of receiving the required licenses, production, costs and expenses; health, safety and environmental risks; marketing and transportation; loss of markets; environmental risks; competition; incorrect assessment of the value of the potential market; ability to access sufficient capital from internal and external sources; failure to obtain required regulatory and other approvals and changes in legislation, including but not limited to tax laws and related regulations. Accordingly, readers should not place undue reliance on the forwardlooking statements, timelines and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive.

The forwardlooking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forwardlooking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws or the Canadian Securities Exchange. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.

Supreme Pharmaceuticals Inc.
Investor Relations
430 – 580 Hornby Street, Vancouver BC, V6C 3B6
(604) 674-2191
info@supreme.ca
www.supreme.ca

Robix Announces Proposed Unit Private Placement

Posted by AGORACOM-JC at 3:04 PM on Thursday, December 11th, 2014

LETHBRIDGE, ALBERTA–(Dec. 11, 2014) - Robix Alternative Fuels Inc. (“Robix” or the “Corporation”) (CSE:RZX) announced today that it intends to complete a non-brokered private placement offering of units at a price of $0.40 per unit for gross proceeds of up to $1,000,000. Each unit will consist of one common share and one-half of one common share purchase warrant. Each whole warrant will entitle the holder thereof to acquire one additional common share at a price of $0.60 per share for a period of one year after the closing.

A finder’s fee of up to 10% of the gross proceeds of the offering may be paid on all or any portion of the funds raised pursuant to this offering. In addition, finders will receive finders warrants equal to up to 10% of the number of units issued in connection with the offering. Each finders warrant will entitle the holder to purchase one common share at a price of $0.40 for a period of one year after the closing.

The closing of the offering is expected to occur on or about December 31, 2014, and is subject to regulatory approval. For further details on the offering, please contact the Corporation. All securities issued in connection with the offering will be subject to a hold period of four months from the date of closing. The net proceeds from the offering will be used to finance the Corporation’s continuing capital program and for general working capital purposes.

About Robix:

The Corporation is an “industrial products/technology” company, offering to investors a unique opportunity to participate in a leading company in the business of ownership of patents, and their development from commercialization to worldwide expansion through various business arrangements. Robix owns a Clean Ocean Vessel (“COV”) patent, which is an oil spill recovery vessel design with the capability to recover oil in rough and debris laden sea conditions. Robix has recognized a worldwide market opportunity for effective containment, recovery and disposal equipment, particularly in the oil spill protection industry, and it proposes to develop a business model as a service provider, and/or equipment provider under licensing agreements with other industry participants, wherein Robix will use its COV patented design solution.

No stock exchange or any securities regulatory body has reviewed the contents of this news release.

This news release may contain certain forward-looking information. All statements included herein, other than statements of historical fact, are forward-looking information and such information involves various risks and uncertainties. There can be no assurance that such information will prove to be accurate, and actual results and future events could differ materially from those anticipated in such information. A description of assumptions used to develop such forward-looking information and a description of risk factors that may cause actual results to differ materially from forward-looking information can be found in the company’s disclosure documents on the SEDAR website at www.sedar.com. The Corporation does not undertake to update any forward-looking information except in accordance with applicable securities laws.

Robix Alternative Fuels Inc.
Nathan Hansen
President & CEO
250-683-8957
nathan@robixfuels.com

Robix Alternative Fuels Inc.
Robin Ray
Chief Financial Officer
403-327-3094
robin@robixfuels.com
www.robixfuels.com

CLIENT FEATURE: QE2 Acquisition Corp. (QE: TSX-V) Revenue Generating Infrastructure Play Capitalizing on the Alberta Advantage

Posted by AGORACOM-JC at 4:11 PM on Wednesday, December 10th, 2014

Why Invest in QE2 Acquisition Corp.?

  • Aggressive Growth by Acquisition
  • $100M 2018 Growth Objective
  • $1.9M in 2013 Normalized EBITDA
  • Experienced, Proven, Driven Management Team

  • Calgary founded firm that acquires, consolidates and grows well managed, profitable, asset backed, Alberta-based businesse in the Infrastructure and Utility Services sectors

  • Recruiting the best expertise in the industry to run day to day operations as well as drive strategic vision

Recent Highlights

  • Signed a letter of intent to acquire a privately-owned accredited electrical contractor located in the Edmonton area (Read Release)
  • Pillar Contracting Ltd. has successfully bid and been awarded a contract by the City Of Calgary to continue the installation phase of 1,000 new LED streetlight heads (Read Release).

Company Portfolio

In April 2014, QE2 Acquisition Corp. completed the acquisition of key assets of Candesto Enterprises Inc.
 

CANDESTO ENTERPRISES LTD.

1450 Bearspaw Dam Rd NW, Calgary, AB T3L 0C3
p: 403-286-7922
About Candesto Enterprises Ltd.
Candesto is a leader in highway signage, guardrail installation services, and miscellaneous fencing with its services primarily engaged in the new construction of roads and highways. Candesto has operated for over 20 years and strategically concentrates its activities in southern Alberta, with the bulk of its customers acting as the project general contractor, working for 1 of the 4 levels of government.
 
Mihalis Belantis, CEO of QE2:
“This acquisition strengthens our portfolio and is aligned with QE2’s strategy: to buy and grow Alberta companies that keep Alberta growing.”
Chris Bokenfohr, GM of Candesto
“I’m excited that Candesto is now part of QE2, and I look forward to continuing to grow Candesto with the help and support of the QE2 team.”
Chris Bokenfohr, a civil engineer and owner of Candesto, will remain as General Manager of Candesto for 5 years and the existing staff is retained.
– – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – -
 
In October 2013, QE2 Acquisition Corp. completed the acquisition of Pillar Contracting Ltd.
 

PILLAR CONTRACTING LTD.
103A, 11129-83 Avenue, AB T8L 3T9
w: www.pillarltd.com
About Pillar Contracting Ltd.:
Pillar is an industry leader in specialized utilities services: maintenance of light post and street light standards, condition surveys including metal fatigue testing, flagging and traffic management. Pillar’s customers primarily consist of municipalities and utility companies. Pillar is an Alberta grown, cash flow positive business with a proven track record and a strong management team.

Mark Lacoursiere, Founder of Pillar Contracting Ltd.:
“QE2 believes in Alberta and the hardworking people that keep this province humming”, states Mark Lacoursiere. “QE2 shares my growth vision for Pillar and my belief in people and relationships. I am excited to see where Pillar will be over the next 3 years with the help of QE2. The future looks bright!”

Mihalis Belantis, CEO of QE2:
“We are proud to welcome Pillar into the QE2 family,” explains Mihalis Belantis. “Pillar’s founder, Mark Lacoursiere, and all Pillar employees are a testament to the entrepreneurial spirit, work ethic and desire to succeed that is so prevalent in Alberta!”

Company History

Albertans created QE2 Acquisition Corp. with the true Alberta spirit of determination, and the desire to create opportunity within the local economy through innovative vision and hard work.

It was an idea six years in the making, formed while living and working within the province’s rural towns and urban centers.The relationships that were forged during this period would eventually culminate to form QE2 – from influential finance professionals to research analysts, salespeople and marketers, to business owners and families.

QE2 is a company forged by a group of organized, motivated and extraordinary people with a vision to do extraordinary things.

 

 

Capitalizing On Alberta’s Growth

INTERVIEW Part 2: Avalon Rare Metals (AVL: TSX) 3 Advanced Stage Projects Capitalizing on Scarce Rare Earth Elements

Posted by AGORACOM-JC at 1:20 PM on Wednesday, December 10th, 2014

AVL: TSX, AVL: NYSE MKT

  • Three advanced stage projects
  • Nechalacho Deposit is exceptional in its size and enrichment in the scarce “heavy” rare earth elements
  • HREE-rich resource in the Basal Zone contains Measured and Indicated Resources of 61.90 million tonnes grading 1.64% TREO (total rare earth oxides) and 21.53% HREO/TREO (heavy rare earth oxides as a percentage of TREO) at the Base Case US$345 Net Metal Return cut-off value
  • Key to enabling advances in clean technology and other growing high-tech applications

Highlights

  • The Nechalacho deposit is rich in the heavy rare earths, which the European Union identified as the critical raw material with the greatest supply risk in May 2014.
  • Avalon has invested approximately $100 million into the Nechalacho Project to date, including $60 million to complete a comprehensive Feasibility Study. Nechalacho is now the most advanced heavy rare earth project in the world outside of China. Results of the discounted cash flow analysis produced for the April 2013 Feasibility Study yielded a pre-tax IRR of 22.5% and an NPV at a 10% discount rate of $1.35 billion, with a payback period of 4.3 years and a $1.575 billion capital cost.
  • Many opportunities were identified in the April 2013 Feasibility Study to optimize the project development model to reduce technical risk and increase revenues. These include improving rare earth recoveries and revising the mine plan to improve operational efficiencies. The most significant optimization was the development of a new hydrometallurgical process that increases recoveries of the heavy rare earths while suppressing recovery of low-value cerium. An updated Feasibility Study is targeted for completion in late 2014.
  • Avalon holds a diverse rare metals project portfolio, including advanced tin (East Kemptville) and lithium minerals (Separation Rapids) properties.
  • The principles of sustainability, environmental and social responsibility are core values of the company.

Corporate Website

Lexaria Oilfield Sale Completed

Posted by AGORACOM-JC at 8:10 AM on Wednesday, December 10th, 2014

KELOWNA, BC / December 10, 2014 / Lexaria Corp. (OTCQB: LXRP) (CSE: LXX) (the “Company” or “Lexaria”) is pleased to announce the sale of all its Belmont Lake oil assets for $1.4 million in cash has closed and all money received. Lexaria congratulates the new owners for having purchased a fine asset.

Lexaria has now repaid all outstanding debts. As a result our monthly expenditures have decreased and we are no longer making interest or principal repayments.

“We are very excited about using our new cash reserves to launch PoViva Tea and pursue our alternative-health business plan,” said Chris Bunka, CEO of Lexaria.

Lexaria is working almost around-the-clock to be able to offer PoViva tea to consumers as quickly as possible. We are hoping to be able to announce our ability to accept pre-orders before Christmas.

We are close to unveiling our new 1st generation PoViva website with an announcement pending in the days to come.

Lexaria is asking all its shareholders to spread the word of PoViva Tea and our patent pending process of delivering CBD, in preparation for sales to commence. We also remind all concerned that the CBD-oil derived from agricultural hemp that PoViva uses is legal in all 50 states and never contains more than inconsequential amounts of THC; less than 0.3%.

About Lexaria

Lexaria’s shares are quoted in the USA with symbol LXRP and in Canada with symbol LXX. The company searches for projects that could provide potential above-market returns.

To learn more about Lexaria Corp. visit www.lexariaenergy.com.

FOR FURTHER INFORMATION PLEASE CONTACT:

Lexaria Corp.
Chris Bunka
Chairman & CEO
(250) 765-6424

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. Access to capital, or lack thereof, is a major risk and there is no assurance that the Company will be able to raise required working capital. Current oil and gas production rates may not be sustainable and targeted production rates may not occur. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that the medical marijuana, CBD sector, or alternative health businesses will provide any benefit to Lexaria, or that the Company will experience any growth through participation in these sectors. There is no assurance that existing capital is sufficient for the Company’s needs or that it will need to attempt to raise additional capital. There is no assurance that and cannabidiol-based product will promote, assist, or maintain any beneficial human health conditions whatsoever. No statement herein has been evaluated by the Food and Drug Administration (FDA). PoViva products are not intended to diagnose, treat, cure or prevent any disease.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Stria Lithium Year End Update Includes Start of Pilot Plant Design for its Novel, Environmentally Sustainable Lithium Processing Technologies

Posted by AGORACOM-JC at 5:31 PM on Tuesday, December 9th, 2014

OTTAWA, ONTARIO–(Dec. 9, 2014) - Stria Lithium Inc. (TXS VENTURE:SRA) (“Stria” or the “Company”) is pleased to announce that following the completion of positive bench scale testing of its proprietary, environmentally sustainable lithium ore processing technologies, the Company has moved into the design stage for its limited production pilot plant.

Company President and Chief Operating Officer Julien Davy said the pilot plant will be designed to produce up to 140 kg per month of lithium compound over a six month period, commencing in early 2015, with the aim of providing potential customers with sufficient 99.99% purity materials for validating process economics and product quality.

Mr. Davy said the pilot plant will be constructed at the Grafoid Global Technology Centre in Kingston, Ontario.

“As a key member of the Grafoid, Focus Graphite battery materials development business platform, Stria completes a potential North American supply solution to both domestic and international battery manufacturers,” Mr. Davy said.

“And, as a mineral mining and technology supplier group, our battery platform is unique in the world,” he added.

Stria Lithium’s business strategy is based upon meeting three key milestones for success. They are: time to market; meeting universal standards for environmental sustainability, and; setting market prices for lithium concentrates.

Stria targets clean energy customers in the automotive, industrial, medical, motorsports, marine, military, avionics and energy storage battery system sectors – the prime movers of demand for the foreseeable future.

With management backgrounds in geological sciences, business development and process engineering, Stria is the sole proprietor of two exploration properties intended to feed its pilot plant development with raw material – the Pontax hard-rock lithium project in Northern Quebec and the Willcox brine lithium project in southeastern Arizona.

Canadian Government Participation

Mr. Davy said the Company’s development advances in producing low-cost, high-purity Li-metal, Li-carbonate and Li-hydroxide products were made possible, in part, by a $137,700 funding commitment from the National Research Council’s Industrial Research Assistance Program (“IRAP”).

The National Research Council’s Industrial Research Assistance Program (NRC-IRAP) is Canada’s premier innovation assistance program for small and medium-sized enterprises (SMEs). It is a vital component of the NRC and a cornerstone in Canada’s innovation system, regarded worldwide as one of the best programs of its kind.

Under the terms of financial commitment announced on November 12, 2014, IRAP will reimburse Stria for salaries paid to scientists and technical staff and for expenses directly related to process development.

Non-Brokered Private Placement

The Company is pleased to announce its private placement offering of non flow-through and flow-through units will remain open until December 29, 2014.

On October 30, 2014, Stria Lithium announced the close of its first tranche of a non-brokered private placement offering of up to $1,000,000.

The total private placement consisted of the sale of up to 2,666,667 non flow-through units (the “Units”) at a price of $0.15 per Unit for gross proceeds of $400,000 and up to 3,157,895 flow-through units (the “Flow-Through Units”) at a price of $0.19 per Flow-Through Unit for proceeds of up to $600,000.

Each Unit consists of one (1) common share of the Company and one (1) warrant (a “Warrant”). Each Flow-Through Unit consists of one (1) flow-through common share of the Company and one (1) Warrant. Each Warrant entitles the holder to acquire one (1) additional common share of the Company at a price of $0.35 for a period of 24 months from closing.

The closing of the first tranche of the non flow-through portion of the Offering realized gross proceeds of $26,650.05 from the issue of 177,667 Units. The closing of the first tranche of the flow-through portion of the Offering realized proceeds of $154,770.20 from the issue of 814,580 Flow-Through Units.

About Stria Lithium Inc.

Stria Lithium (TSX VENTURE:SRA) owns the Pontax spodumene lithium property in Northern Quebec and the Willcox brine lithium property in southeastern Arizona. As announced in January 2014, Stria is developing proprietary, in-house processing technologies for both projects with the purpose of reducing processing costs on an environmentally sustainable basis.

Stria’s technologies, based on recovering lithium metal directly from ore and from brine liquids, will be more efficient, will require fewer controls, less chemistry and require less energy from compact facilities designed to enable easy automation.

Forward Looking Statement – Disclaimer

This news release may contain forward-looking statements, being statements which are not historical facts, and discussions of future plans and objectives. There can be no assurance that such statements will prove accurate. Such statements are necessarily based upon a number of estimates and assumptions that are subject to numerous risks and uncertainties that could cause actual results and future events to differ materially from those anticipated or projected. Important factors that could cause actual results to differ materially from the Company’s expectations are in our documents filed from time to time with the TSX Venture Exchange and provincial securities regulators, most of which are available at www.sedar.com.

Stria Lithium Inc.
Mr. Julien Davy
President and COO
613-241-4040
jdavy@strialithium.com

QE2 Acquisition Corp. Announces Resignation of Director

Posted by AGORACOM-JC at 4:40 PM on Tuesday, December 9th, 2014

CALGARY, ALBERTA / December 9th, 2014 / QE2 Acquisition Corp. (“QE2″ or the “Corporation”) (TSX VENTURE:QE) announces the resignation of Robb McNaughton, LLB, partner in law firm Borden Ladner Gervais LLP, Calgary, as a Director of the Corporation effective immediately.

Mike Belantis, QE2’s CEO, comments, “Robb was instrumental in helping QE2 complete the Qualifying Transaction with Crowsnest Acquisition Corp. and we sincerely thank him for that and wish him every success for the future. As QE2 continues to grow through its acquisitions program of infrastructure and utility service companies, it is going to be increasingly important that we strengthen our Board with operational and financial expertise and experience. We look forward to reporting our progress towards that goal in due course.”

About QE2 Acquisition Corp. (www.qe2corp.com):

QE2 is a forward thinking, Alberta-founded firm that acquires and grows well-managed, profitable, asset-backed, Alberta-based businesses in the infrastructure and utility service sectors. QE2’s growth strategy is a mergers and acquisitions program which leverages the synergies that can be achieved by vertical and horizontal integration. For further information, please contact Mihalis Belantis, CEO and Director, #4034, 909 – 17th Avenue SW, Calgary, Alberta, T2T 0A4, Tel: (403) 478-0055, Fax: (403) 770-8468, Email: info@qe2corp.com.

Cautionary Statements

Statements in this press release may contain forward-looking. The words “will,” “anticipate,” believe,” “estimate,” “expect,” “intent,” “may,” “project,” “should,” and similar expressions are intended to be among the statements that identify forward-looking statements. The forward-looking statements are founded on the basis of expectations and assumptions made by the Corporation. Readers are cautioned that assumption used in the preparation of such information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Corporation. The Corporation does not have any obligation to update or revise any forward-looking statements except as expressly required by applicable securities laws.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

The securities of QE2 have not been and will not be registered under the United States Securities Act of 1933, as amended and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirement. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.

Not for distribution to U.S. Newswire Services or for dissemination in the United States of America. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.

CLIENT FEATURE: Xylitol (XYL:TSX-V) Natural Sweetener Co with $6.5M in 2013 Revenue

Posted by AGORACOM-JC at 11:20 AM on Tuesday, December 9th, 2014

Financial Highlights

  • Revenues For the third quarter ended September 30, 2014 was $2.2M versus $1.4M for the same period last year.
  • Revenues for the nine months ended September 30, 2014 was $6.3M versus $3.9M for the same period last year.
  • For the twelve months ended December 31, 2013, sales increased by 87% to $6,508,998, compared to $3,473,053 for the twelve months ended December 31, 2012.

Marquee Customers Include:

Strong Institutional Ownership

  • Dundee Corp 29%
  • SunOpta BioProcess Inc. 26%

What is Xylitol you ask?

  • Xylitol is a sugar alcohol – and no, that doesn’t mean there’s alcohol in it. It’s also known as a polyol. Sugar alcohols contain fewer calories and fewer carbohydrates than other sweeteners. Replacing sugar with xylitol can be helpful if you’re trying to lose weight or even to help prevent weight gain.

What does xylitol taste like?

  • Xylitol is a white crystalline granule that looks and tastes like sugar. The good news is that it doesn’t have the negative side effects associated with sugar. Xylitol is low-calorie, low-carb, diabetic safe and we think it’s guilt free!

Where does your xylitol come from?

  • Xyla brand xylitol is extracted from North American grown hardwood trees, and it’s delicious. We believe the practices employed in the harvesting and processing of our xylitol are ecologically sustainable. Xylitol is also naturally occurring in many fruits and vegetables. Did you know the human body makes about 15 grams of xylitol per day?

Xylitol Canada, Inc. emerged in 2004 as a reseller and distributor of Xylitol and Xylitol products. Based in Toronto, Ontario, the company continued to grow and develop additional brands under the names Sweet Diabetic Delight and Xylitol Canada. Realizing the market potential for high quality, readily available, and consistently priced Xylitol and Xylitol products, the Company broadened its strategic vision in 2009.

Realizing that the void in the Xylitol market was based on inadequate supply and lack of awareness, the company initiated a 2-tier business expansion plan that sought to solve both of these problems. With the vision of a full scale North American Xylitol production facility as a critical element of this strategy, the Company reached out to the Capital markets and formally went public in April of 2010. With the capital base to aggressively address the marketplace, the company immediately began executing its business plan.

Xylitol In The Media

Daytime Toronto – Rogers TV (Aug 2013) – Julie Reid from Xylitol Canada appears with Mari Loewen from Anna Magazine to make some delicious recipes using North American hardwood derived Xyla xylitol.

Daytime Ottawa – Rogers TV (June 2013) - Xylitol Canada’s Julie Reid and naturopath Helene Huot discuss the benefits of Xyla xylitol and share great summer recipes using Xyla.

Is Sugar Toxic? – 60 Minutes (May 4th, 2013) – Sugar is the most addictive substance on earth. It’s also the most dangerous and toxic substance anyone can consume. Sugar has similar affects on the brain like cocaine. Heart disease, cancer, diabetes type II and many more are linked to processed sugar.

Sugary Drinks Linked To 180,000 Deaths Worldwide – CNN (March 19, 2013) – “One in every 100 deaths from obesity-related diseases is caused by drinking sugary beverages,” says study author Gitanjali Singh, a postdoctoral research fellow at the Harvard School of Public Health.

Hub On AGORACOM / Corporate Website

Enertopia Provides Burlington MMPR Update

Posted by AGORACOM-JC at 8:23 AM on Tuesday, December 9th, 2014

VANCOUVER, BC / December 9, 2014 / Enertopia Corporation (ENRT-OTCBB) (TOP-CSE) (the “Company” or “Enertopia”) is pleased to announce that Health Canada has advised the Company that the Burlington, Ontario application has advanced to the Enhanced Screening Stage of the application process.

The company is pleased to advise shareholders that its license application with joint venture partner, Lexaria Corp (LXRP), submitted for licensed producer in July 2014 is now at the Enhanced Screening process. Ontario Operations Manager Mr. Donald Shaxon is the responsible person in charge of the Burlington JV.

The Burlington Joint Venture with Lexaria Corp has applied to produce 10,000kg of Medical Marihuana per year under its Licensed Producer application. Enertopia has 51% interest in the joint venture and Lexaria Corp 49% as disclosed on April 9, 2014 in Enertopia’s press release #201424 and press release #201439.

The Burlington JV has requested a Ready to build letter from Health Canada once the application has made it through step 4 of the approval process.

For those not familiar with the Health Canada process for becoming a licensed producer, below are the levels to be reached through the application process. Note there are no specific process times for each step:

Step 1: Preliminary Screening (Completed)
Step 2: Enhanced Screening (Underway)
Step 3: Security Clearance
Step 4: Review
Step 5: Ready to build letter (if required by applicant)
Step 6: Pre-licence inspection
Step 7: Licensing

The Joint Venture (JV) has been active in the local community and has received very good community and media support. The JV also met with the local policing authority and upon licensing by Health Canada we have proposed that the local police could conduct security and swat team training at the facility. We are very pleased to be working closely with law enforcement and look forward to their insights in preventative and proactive security measures.

On November 24, 2014 Health Canada updated the number of Licensed Producers to grow and sell Marijuana to 14 and the number of Licensed Producers to grow Marijuana at 8 for a current total of 22 Licensed Producers in Canada.

Enertopia looks forward to the next steps in the application process and receiving a letter to build in 2015. In 2015 Enertopia we will be launching education and wellness seminars to help educate the public and medical community on the responsible and educated uses of Medical Marijuana” Stated President / CEO Robert McAllister.

About Enertopia

Enertopia’s shares are quoted in Canada with symbol TOP and in the United States with symbol ENRT. For additional information, please visit www.enertopia.com or call

Clark Kent, Media Inquiries: (647) 519-2646

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, potential licensing and financing of its medical marihuana projects, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions that are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements., foreign exchange and other financial markets; changes of the interest rates on borrowings; hedging activities; changes in commodity prices; changes in the investments and exploration expenditure levels; litigation; legislation; environmental, judicial, regulatory, political and competitive developments in areas in which Enertopia Corporation operates. The User should refer to the risk disclosures set out in the periodic reports and other disclosure documents filed by Enertopia Corporation from time to time with regulatory authorities. There is no assurance that the Burlington Joint Venture will obtain a license under MMPR and or that the Company will receive a letter to build in 2015 or be able to obtain future financings.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks